Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$51.4B |
| 2 |
Broadcom
AVGO
|
+$8.12B |
| 3 |
NVIDIA
NVDA
|
+$6.62B |
| 4 |
UnitedHealth
UNH
|
+$5.92B |
| 5 |
Apple
AAPL
|
+$5.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$14.9B |
| 2 |
Meta Platforms (Facebook)
META
|
+$12.7B |
| 3 |
SNDK
Sandisk
SNDK
|
+$7.89B |
| 4 |
Netflix
NFLX
|
+$6.05B |
| 5 |
Coherent
COHR
|
+$4.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.62% |
| 2 | Industrials | 10.81% |
| 3 | Communication Services | 9.9% |
| 4 | Healthcare | 9.29% |
| 5 | Financials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
QuidelOrtho
QDEL
$729M
| $129M | 0.01% |
7,363,696
+772,544
| +12% | +$10.2M |
|
1127
iShares Russell 3000 ETF
IWV
$20.1B
| $129M | 0.01% |
301,846
-86,102
| -22% | -$35.5M |
|
1128
DraftKings
DKNG
$12.2B
| $128M | 0.01% |
5,071,489
-4,288,490
| -46% | -$106M |
|
1129
Concentrix
CNXC
$1.78B
| $128M | 0.01% |
5,712,934
+1,489,652
| +35% | +$38.8M |
|
1130
Blue Owl Capital
OBDC
$5.46B
| $128M | 0.01% |
11,772,285
-74,832
| -0.6% | -$837K |
|
1131
Fidelity Value Factor ETF
FVAL
$1.37B
| $128M | 0.01% |
1,637,699
-46,088
| -3% | -$3.53M |
|
1132
DexCom
DXCM
$32.6B
| $128M | 0.01% |
1,893,246
+220,210
| +13% | +$14.7M |
|
1133
Avantis US Large Cap Value ETF
AVLV
$21.5B
| $127M | 0.01% |
1,397,539
+134,765
| +11% | +$11.8M |
|
1134
Intapp
INTA
$2.87B
| $127M | 0.01% |
5,054,981
+663,151
| +15% | +$15.1M |
|
|
FLOC
1135
Flowco Holdings
FLOC
$903M
| $127M | 0.01% |
5,966,779
+1,457,696
| +32% | +$34.8M |
|
|
SEI
1136
Solaris Energy Infrastructure
SEI
$4.06B
| $127M | 0.01% |
1,581,402
-281,159
| -15% | -$20.1M |
|
1137
LCI Industries
LCII
$2.13B
| $126M | 0.01% |
1,194,677
-840,034
| -41% | -$92.4M |
|
1138
iShares MSCI EAFE Growth ETF
EFG
$16.4B
| $126M | 0.01% |
1,015,901
+25,819
| +3% | +$3.11M |
|
1139
California Resources
CRC
$5.12B
| $126M | 0.01% |
2,378,033
+768,190
| +48% | +$47.3M |
|
1140
JPMorgan Limited Duration Bond ETF
JPLD
$4.01B
| $125M | 0.01% |
2,401,346
+2,396,655
| +51,090% | +$125M |
|
1141
Arcus Biosciences
RCUS
$3.1B
| $125M | 0.01% |
4,049,757
+2,884,505
| +248% | +$71.3M |
|
1142
Kirby Corp
KEX
$7.34B
| $125M | 0.01% |
917,664
+123,111
| +15% | +$17.6M |
|
1143
Vanguard Dividend Appreciation ETF
VIG
$111B
| $125M | 0.01% |
527,214
+27,401
| +5% | +$6.29M |
|
1144
Lexicon Pharmaceuticals
LXRX
$894M
| $124M | 0.01% |
51,782,045
+6,725,707
| +15% | +$13.1M |
|
1145
Pinnacle West Capital
PNW
$11.5B
| $124M | 0.01% |
1,158,402
+1,077,741
| +1,336% | +$110M |
|
1146
CytomX Therapeutics
CTMX
$586M
| $123M | 0.01% |
32,714,937
+759,300
| +2% | +$2.9M |
|
1147
Vanguard Financials ETF
VFH
$13.3B
| $122M | 0.01% |
930,485
-34,159
| -4% | -$4.36M |
|
1148
F5
FFIV
$24.4B
| $122M | 0.01% |
292,659
+112,973
| +63% | +$40.1M |
|
1149
Mineralys Therapeutics
MLYS
$2.56B
| $122M | 0.01% |
4,511,689
-349,415
| -7% | -$9.59M |
|
1150
Cirrus Logic
CRUS
$6.12B
| $122M | 0.01% |
819,375
+185,672
| +29% | +$30.4M |
|
Similar funds
Fidelity Investments's Q2 2026 Portfolio in Review
As of Q2 2026, Fidelity Investments held 5,773 positions worth $2.3T, up 21% from $1.9T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fidelity Investments's Q2 2026 filing shows 351 new, 2,921 increased, 1,859 reduced and 211 closed positions. Its largest new stake was SpaceX: 302,555,831 shares worth $51.7B. The largest sale was Marvell Technology, an estimated $14.9B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 32% a quarter earlier, followed by Industrials and Communication Services.
- Fidelity Investments's largest Q2 2026 buy was SpaceX: 302,555,831 shares worth $51.7B.
- Fidelity Investments added most to Broadcom in Q2 2026, an estimated $8.12B increase.
- Fidelity Investments's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $14.9B.
- Fidelity Investments fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $272M.
- Fidelity Investments's ten largest holdings make up 34% of its $2.3T portfolio in Q2 2026.
- Fidelity Investments opened 351 new positions and closed 211 in Q2 2026.
- Fidelity Investments's portfolio value rose 21% quarter-over-quarter to $2.3T.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.